News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News TCT 2024 ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation Yael L. Maxwell October 29, 2024
News Conference News TCT 2023 ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation Todd Neale October 26, 2023
News Conference News TCT 2022 Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning Shelley Wood September 19, 2022
News Conference News TCT 2022 Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve Todd Neale September 19, 2022
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020
News Conference News TCT 2019 Portico Noninferior to Commercial TAVR Valves in IDE Study Caitlin E. Cox September 27, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019
News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
News Conference News TCT 2015 Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves Todd Neale October 15, 2015
News Conference News TCT 2015 Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR October 11, 2015
News Conference News TCT 2015 Global TAVR Market Poised to Exceed DES Market by 2025 October 11, 2015